跳至主要内容
临床试验/DRKS00033981
DRKS00033981招募中不适用

ungtech-RETRO Evaluation of stereotactic body radiation therapy (SBRT) of centrally located lung tumors

Klinik für Strahlentherapie und Radioonkologie der Universitätsklinik Bonn0 个研究点目标入组 200 人开始时间: 2024年4月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • SBRT for centrally located early-stage NSCLC or central lung metastasis
  • - Lesions in which a malignant tumor has been confirmed either by histology/cytology or by clear imaging evidence (suspected CT, growth, FDG scan)
  • - No previous radiotherapy of the thorax and/or mediastinum
  • - BED of at least 70 Gy (a/ß= 10; at least EQD-2 = 62.5 Gy) with highly conformal, image-guided radiotherapy technique
  • - Any fractionation is acceptable as long as the BED is 70 Gy or more (EQD-2 = 62.5 Gy)

排除标准

  • - SBRT of peripheral tumors
  • - Pre-irradiation of the thorax and/or mediastinum
  • - Biologically effective dose (BED) of less than 70 Gy (a/ß= 10; minimum EQD-2 = 62.5 Gy)

研究者

发起方
Klinik für Strahlentherapie und Radioonkologie der Universitätsklinik Bonn

相似试验